Atlas Trials

A Phase I Study of a Single Dose of Radio-labeled BMS-275183 in Patients With Advanced Cancer

Clinical trial NCT00326131 · TERMINATED

Trial details

NCT number
NCT00326131
Sponsor
Bristol-Myers Squibb
Status
TERMINATED
Phase
Phase 1
Study type
INTERVENTIONAL
Cancer
Start date
2006-04-01
Primary completion
2007-03-01
Enrollment
6

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.